Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hospital admission due to infections in multiple sclerosis patients
Scott Montgomery, Jan Hillert, Shahram Bahmanyar
European Journal of Neurology (2013) Vol. 20, Iss. 8, pp. 1153-1160
Closed Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
Gustavo Luna, Peter Alping, Joachim Burman, et al.
JAMA Neurology (2019) Vol. 77, Iss. 2, pp. 184-184
Open Access | Times Cited: 424
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis
Amber Salter, Samantha Lancia, Gary Cutter, et al.
Multiple Sclerosis Journal (2025)
Closed Access | Times Cited: 2
A Nationwide Study on the Risk of Autoimmune Diseases in Individuals With a Personal or a Family History of Schizophrenia and Related Psychosis
Michael E. Benros, Marianne Giørtz Pedersen, Helle Rasmussen, et al.
American Journal of Psychiatry (2013) Vol. 171, Iss. 2, pp. 218-226
Closed Access | Times Cited: 182
The role of infections in multiple sclerosis
Mariano Marrodán, Lucas Alessandro, Mauricio Farez, et al.
Multiple Sclerosis Journal (2019) Vol. 25, Iss. 7, pp. 891-901
Open Access | Times Cited: 120
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database
Gorana Capkun, Frank Dahlke, Raquel Lahoz, et al.
Multiple Sclerosis and Related Disorders (2015) Vol. 4, Iss. 6, pp. 546-554
Open Access | Times Cited: 102
COVID-19 Among Patients With Multiple Sclerosis
Mahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 4
Open Access | Times Cited: 98
Dramatically changing rates and reasons for hospitalization in multiple sclerosis
Ruth Ann Marrie, Lawrence Elliott, James Marriott, et al.
Neurology (2014) Vol. 83, Iss. 10, pp. 929-937
Open Access | Times Cited: 97
Infection-related health care utilization among people with and without multiple sclerosis
José M.A. Wijnands, Elaine Kingwell, Feng Zhu, et al.
Multiple Sclerosis Journal (2016) Vol. 23, Iss. 11, pp. 1506-1516
Closed Access | Times Cited: 93
Who and when to vaccinate against influenza
Philippe Buchy, Selim Badur
International Journal of Infectious Diseases (2020) Vol. 93, pp. 375-387
Open Access | Times Cited: 87
COVID-19 in multiple sclerosis patients and risk factors for severe infection
Farhan Chaudhry, Helena Bulka, Anirudha Rathnam, et al.
Journal of the Neurological Sciences (2020) Vol. 418, pp. 117147-117147
Open Access | Times Cited: 79
Infections in patients diagnosed with multiple sclerosis: A multi-database study
Rebecca Persson, S. Lee, Marianne Ulcickas Yood, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 41, pp. 101982-101982
Closed Access | Times Cited: 78
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies
Christoph Metze, Alexander Winkelmann, Micha Loebermann, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 25, Iss. 2, pp. 245-254
Open Access | Times Cited: 76
COVID-19 in teriflunomide-treated patients with multiple sclerosis
Amir Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, et al.
Journal of Neurology (2020) Vol. 267, Iss. 10, pp. 2790-2796
Open Access | Times Cited: 60
Review of the COVID-19 Risk in Multiple Sclerosis
Farhan Chaudhry, Cristina Jageka, Phillip D. Levy, et al.
Journal of Cellular Immunology (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 43
Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
Brandi Vollmer, Andrew B. Wolf, Stefan Sillau, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 35
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Silvia Delgado, Simon Faissner, Ralf A. Linker, et al.
Journal of Neurology (2023) Vol. 271, Iss. 4, pp. 1515-1535
Open Access | Times Cited: 17
Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans
Richard E. Nelson, Yan Xie, Scott L. DuVall, et al.
International Journal of MS Care (2015) Vol. 17, Iss. 5, pp. 221-230
Open Access | Times Cited: 54
Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012
Sarah Burkill, Scott Montgomery, MohammadHossein Hajiebrahimi, et al.
Neurology (2017) Vol. 89, Iss. 6, pp. 555-562
Closed Access | Times Cited: 49
Infections in patients with multiple sclerosis: A national cohort study in Sweden
Anna Castelo‐Branco, Flaminia Chiesa, Simona Conte, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 45, pp. 102420-102420
Open Access | Times Cited: 45
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
Luca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Journal of Neurology (2022) Vol. 269, Iss. 5, pp. 2275-2285
Open Access | Times Cited: 28
Risk of serious infections in multiple sclerosis patients by disease course and disability status: Results from a Swedish register-based study
Judith S. Brand, Kelsi A Smith, Fredrik Piehl, et al.
Brain Behavior & Immunity - Health (2022) Vol. 22, pp. 100470-100470
Open Access | Times Cited: 21
Association of autoimmune diseases with the occurrence and 28-day mortality of sepsis: an observational and Mendelian randomization study
Hui Li, Xiaojun Pan, Sheng Zhang, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 12
Patient level dataset to study the effect of COVID-19 in people with Multiple Sclerosis
Hamza Khan, Lotte Geys, Peer Baneke, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies
Paolo Pellegrino, Carla Carnovale, Valentina Perrone, et al.
Vaccine (2014) Vol. 32, Iss. 37, pp. 4730-4735
Closed Access | Times Cited: 39
Early comorbidities and diagnostic challenges in people with multiple sclerosis with possible impact on disease management
Christine Makarov, Ewan Donnachie, Alexander Hapfelmeier, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2025) Vol. 11, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top